Xianju pharmaceutical has obtained 13 kinds of APIs GMP certificate
-
Last Update: 2019-08-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On August 13, Xianju pharmaceutical recently received the GMP certificate of the people's Republic of China (zj2019093) approved and issued by Zhejiang drug administration, which is valid until August 4, 2024 It is understood that the certification scope of this certificate is API (prednisone acetate, mifepristone, prednisolone acetate, prednisolone acetate, norethisterone, progesterone, mometasone furoate, betamethasone dipropionate, dexamethasone sodium phosphate, dexamethasone acetate, triamcinolone acetate, dexamethasone, triamcinolone acetonide) Xianju pharmaceutical said that the transfer to the new API plant is conducive to the improvement of the company's production and quality management system, and lays a solid foundation for the company's API development The company will continue to maintain stable production management and product quality, better meet market demand and enhance the company's profitability.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
